India M&As Overtook PE Activity In 2022, Deal Momentum To Continue In 2023

Biocon-Viatris Deal Largest

 
• By Vibha Ravi
  
India
Indian Pharma's M&A Activity Expected To Continue In 2023 • Source: Shutterstock

More from Global Vision

More from In Vivo